NT PHARMA: Zhang Bozhi appointed as CEO

Zhitong
2025.05.19 04:08
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, NT PHARMA announced that as the company's business scale expands and considering the needs for the next phase of the company's development, Mr. Wu Tie wishes to dedicate more time to focus on the group's development strategy and other matters, therefore he has resigned from the position of Chief Executive Officer, effective from May 19, 2025. Mr. Wu Tie will continue to serve as the Chairman of the Board and Executive Director. Mr. Zhang Bozhi has been appointed as the Chief Executive Officer, effective from May 19, 2025

According to the Zhitong Finance APP, NT PHARMA (01011) announced that as the company's business scale expands and considering the needs for the next phase of development, Mr. Wu Tie wishes to dedicate more time to focus on the group's development strategy and other matters, and has therefore resigned from the position of Chief Executive Officer, effective May 19, 2025. Mr. Wu Tie will continue to serve as the Chairman of the Board and Executive Director.

Mr. Zhang Bozhi has been appointed as the Chief Executive Officer, effective May 19, 2025

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.